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Objectives: To gage the need, understanding and wish to discuss Palliative Care
(PC) and/or End of Life Care directive for PWCF with CF teams and/or family.
To give PWCF the forum to discuss end of life care EOLC/PC if they so wish. To
research best practices in our CF centres for EOLC/PC involvement. To support CF
teams in any way possible through awareness and education on issues surrounding
EOLC if needed.
Method: This is an ongoing project; to date,
– Meetings have been held with representative from the CFAI, Irish Hospice
Foundation (IHF), CF Multidisciplinary Teams and CF Patient Advocate.
– PWCF patient group held a teleconference meeting to discuss EOLC.
– A questionnaire was developed and sent to CF centres to ask for their opinion
and policies on EOLC.
– A draft discussion paper for PWCF, CF families, and CF teams is available for
comment.
– A poster has been devised in conjunction with the IHF as a starting block for
further research and education on EOLC/PC for PWCF.
Conclusion: Doing this research has opened the doorway for discussion between
CF teams, CFAI and patient groups. For PWCF it gives freedom to discuss EOLC
issues freely with one another. The feedback received from the multidisciplinary
teams to date will result in a stepping stone to support literature being developed for
healthcare professionals caring for PWCF. Further discussions with psychologists
working on CF multidisciplinary teams, with the aim of producing information
leaﬂets on the issues surrounding EOLC. We have a produced a poster which
identiﬁes the main areas we need to develop as an association.
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Introduction: The respiratory system of cystic ﬁbrosis (CF) patients presents
chronic inﬂammation with a thickness of the mucus and decrease of the ciliar
mobility. Causing, between many manifestations, chronic cough that affects quality
of life and social relations.
Objective: Validate the Spanish version of the Leicester Cough Questionnaire
(LCQ) in a population of CF children.
Methods: After the adaptation to Spanish, the sample was formed by patients
between 7 and 18 years old, with a total of 58 individuals, from Corporacio´n Parc
Taullı´ (Sabadell) and Asociacio´n Madrilen˜a Contra la Fibrosis Quı´stica (Madrid) in
Spain. The questionnaire was administered twice in stable disease patients in order
to contrast the results.
Results: The population was composed by 62% male and 38% female, with a
medium (SD) age of 11.7 (3.1) and BMI of 19 (13). The total values were LCQ1
18.46 (2.4) vs LCQ2 18.69 (2.3) (p = 0.769). The Cronbach’s alpha coefﬁcients was
0.86 LCQtotal; 0.76 LCQphysical; 0.79 LCQpsychological and 0.78 LCQsocial.
The intraclass correlation coefﬁcients was LCQphysical 0.82 (p< 0.01), LCQpsy-
chological 0.75 (p< 0.01), LCQsocial 0.63 (p< 0.01) and LCQtotal 0.83 (p< 0.01).
The relations with the CF quality of life questionnaire shows a relation of r = 0.51
(p< 0.01) with the respiratory symptoms domain for the child version and r = 0.67
(p< 0.05) for the same domain for teenagers. Also, there were relations between
the LCQ and the pulmonary function like FVC (LCQphysical 0.42, p< 0.01;
LCQpsychological r = 0.60, p< 0.01; LCQsocial r = 0.46, p< 0.01 and LCQtotal
r = 0.55 with an p< 0.01).
Conclusion: The Spanish version of the LCQ is reliable and valid to CF patients.
